Your session is about to expire
← Back to Search
OCS Liver Preservation for Liver Transplant
Study Summary
This trial will test a new system for preserving and assessing donor livers for transplant. The goal is to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a solid organ or bone marrow transplant.I am on the liver transplant waiting list.I am 18 years old or older.I am experiencing sudden severe liver failure.
- Group 1: OCS Preserved Livers
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available for potential participants in this research endeavor?
"Clinicaltrials.gov details that this trial, which was originally made available on July 24th 2020 and last updated a few weeks ago, is not currently enrolling patients. However, there are 52 other medical studies actively recruiting participants at the present time."
In what quantity of medical facilities is this experiment being conducted?
"Those interested in participating in this trial should look to the Massachusetts General Hospital located in Boston, MA; Stanford University situated near Palo Alto, CA; and Montefiore Medical Centre of Bronx, NY. Additionally, 11 other sites are recruiting for the study."
Share this study with friends
Copy Link
Messenger